MetalloBio is an antimicrobials development company working on completely novel types of antibacterial compounds. Series 1 compounds are candidate antibiotics for complicated and difficult-to-treat infections. Series 2 compounds are the basis of new coatings for medical devices such as catheters and orthopaedic implants.

MetalloBio antibacterials are fast-acting bactericides which work through novel modes of action. An advanced Series 1 candidate, KLS-116, has at least two killing activities and elicits minimal resistance.  Series 2 compounds, with a different bactericidal function, function in coatings with tunable antibacterial properties. MetalloBio compounds can also penetrate and disrupt the biofilms seen in many untreatable infections.